285 related articles for article (PubMed ID: 21983157)
1. A recombinant Bacille Calmette-Guérin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice.
Arama C; Waseem S; Fernández C; Assefaw-Redda Y; You L; Rodriguez A; Radošević K; Goudsmit J; Kaufmann SH; Reece ST; Troye-Blomberg M
Vaccine; 2012 Aug; 30(37):5578-84. PubMed ID: 21983157
[TBL] [Abstract][Full Text] [Related]
2. Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guérin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice.
Arama C; Assefaw-Redda Y; Rodriguez A; Fernández C; Corradin G; Kaufmann SH; Reece ST; Troye-Blomberg M
Vaccine; 2012 Jun; 30(27):4040-5. PubMed ID: 22521849
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Mycobacterium bovis BCG producing the circumsporozoite protein of Plasmodium falciparum FCC-1/HN strain induces strong immune responses in BALB/c mice.
Zheng C; Xie P; Chen Y
Parasitol Int; 2002 Mar; 51(1):1-7. PubMed ID: 11880222
[TBL] [Abstract][Full Text] [Related]
4. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
Meraldi V; Romero JF; Kensil C; Corradin G
Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum.
Teo WH; Nurul AA; Norazmi MN
Trop Biomed; 2012 Jun; 29(2):239-53. PubMed ID: 22735846
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice.
Lumsden JM; Nurmukhambetova S; Klein JH; Sattabongkot J; Bennett JW; Bertholet S; Fox CB; Reed SG; Ockenhouse CF; Howard RF; Polhemus ME; Yadava A
Vaccine; 2012 May; 30(22):3311-9. PubMed ID: 22425788
[TBL] [Abstract][Full Text] [Related]
7. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
10. The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert.
Radosevic K; Rodriguez A; Lemckert AA; van der Meer M; Gillissen G; Warnar C; von Eyben R; Pau MG; Goudsmit J
Clin Vaccine Immunol; 2010 Nov; 17(11):1687-94. PubMed ID: 20826614
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein.
Braga CJ; Massis LM; Sbrogio-Almeida ME; Alencar BC; Bargieri DY; Boscardin SB; Rodrigues MM; Ferreira LC
Vaccine; 2010 Feb; 28(5):1373-82. PubMed ID: 19932669
[TBL] [Abstract][Full Text] [Related]
13. Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome.
Speranza V; Colone A; Cicconi R; Palmieri G; Giovannini D; Grassi M; Mattei M; Sali M; Delogu G; Andreola F; Colizzi V; Mariani F
Microb Pathog; 2010 May; 48(5):150-9. PubMed ID: 20219669
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory effects of Leishmania infantum HSP70 recombinant protein on dendritic cells in vitro and in vivo.
Rasouli M; Karimi MH; Kalani M; Ebrahimnezhad S; Namayandeh M; Moravej A
Immunotherapy; 2014; 6(5):577-85. PubMed ID: 24896626
[TBL] [Abstract][Full Text] [Related]
15. Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum.
Zheng C; Xie P; Chen Y
Vaccine; 2001 Dec; 20(5-6):914-9. PubMed ID: 11738757
[TBL] [Abstract][Full Text] [Related]
16. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone.
Stewart VA; McGrath SM; Dubois PM; Pau MG; Mettens P; Shott J; Cobb M; Burge JR; Larson D; Ware LA; Demoitie MA; Weverling GJ; Bayat B; Custers JH; Dubois MC; Cohen J; Goudsmit J; Heppner DG
Infect Immun; 2007 May; 75(5):2283-90. PubMed ID: 17307942
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
Matsumoto S; Yukitake H; Kanbara H; Yamada T
J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886
[TBL] [Abstract][Full Text] [Related]
18. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
19. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.
Lalvani A; Moris P; Voss G; Pathan AA; Kester KE; Brookes R; Lee E; Koutsoukos M; Plebanski M; Delchambre M; Flanagan KL; Carton C; Slaoui M; Van Hoecke C; Ballou WR; Hill AV; Cohen J
J Infect Dis; 1999 Nov; 180(5):1656-64. PubMed ID: 10515829
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
